论文部分内容阅读
我们用上海信谊化学制药厂出品的晕海宁(每片含量50毫克),在航行期间对两条舰船的63名乘员,进行了临床防治观察。现将观察结果简单报告如下。(一)方法1.防治对象:以在风浪航行中,具有晕船征象(呕吐、眩晕)较重者,作为服药、观察对象。干部战士共84名。2.观察分组:第一组:44例,其中23例服药,21例作为对照,观察二个航行日。第二组:40例,全部服药。另外选平日不晕船的40例作为对照,观察二天。
We used halo Xining (50 mg per tablet) produced by Shanghai Xinyi Chemical Factory to observe the clinical prevention and treatment of 63 crew members of the two warships during the voyage. The observations are now simply reported as follows. (A) Method 1. Control object: In the wind and waves sailing, with seasickness signs (vomiting, vertigo) heavier, as the medication, observation object. A total of 84 cadres soldier. 2. Observation group: The first group: 44 cases, of which 23 cases of medication, 21 cases as a control, observed two sailing days. The second group: 40 cases, all taking medicine. In addition to the election on weekdays not seasick 40 cases as a control, observe two days.